Nyxoah (NYXH) raises $95M via public offering to fund U.S. commercial growth and Genio system R&D. Stock ticks up in premarket.read more...
Benzinga
More News
FDA Milestones Fueling Expansion
The biotechnology sector delivered several notable developments. $TNGX, $NTHI, $AIM, $AZN, $NRIX, $NYXH
24-7 Market News
Why Is NYXH Stock Falling Today?
The company priced its stock offering on Friday at a steep discount, with proceeds to be used to expand commercialization activities in the United States.
Stocktwits
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates
Nyxoah (NYXH) delivered earnings and revenue surprises of +19.88% and +4.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of +57.17% and -6.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Nyxoah (NYXH) Projected to Post Earnings on Tuesday
Nyxoah (NASDAQ:NYXH) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-nyxoah-sa-stock...
MarketBeat
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Nyxoah (NYXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Tenet Healthcare (THC) Q1 Earnings Top Estimates
Tenet (THC) delivered earnings and revenue surprises of +14.39% and -0.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Nyxoah (NASDAQ:NYXH) Price Target Lowered to $8.00 at Stifel Nicolaus
Stifel Nicolaus reduced their price target on shares of Nyxoah from $10.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday...
MarketBeat
Nyxoah SA (NASDAQ:NYXH) Receives Consensus Rating of "Moderate Buy" from Brokerages
Nyxoah SA (NASDAQ:NYXH - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has...